Exec Director, Viral Vector Process Development

Role: Senior leader overseeing end-to-end viral vector development for cell and gene therapies, with a focus on scalable platform technologies supporting clinical and commercial manufacturing. Responsibilities: define technical strategy for lentiviral vector platforms; lead process development including upstream and downstream operations; drive process scale-up, tech transfer, and lifecycle management; ensure vector design aligns with cell therapy goals; collaborate cross-functionally with Research, Data, and Manufacturing teams; contribute to regulatory strategy and compliance with cGMP standards; build and lead a high-performing organization in a matrixed environment; influence senior leadership and represent the organization externally. Requirements: PhD in Biochemical Engineering, Molecular Biology, Virology or related field with 15+ years (PhD) or 18+ years (MS) of experience in viral vector development, specifically LVV/RVV systems; deep expertise in vector design, process development, and manufacturing support; experience with cell therapy programs such as CAR-T; comprehensive understanding of regulatory requirements and GxP environment; proven leadership in a highly matrixed, fast-paced setting. Preferred: exposure to in vivo gene delivery platforms and CMC strategies. High-Value: expertise in viral vector development for cell/gene therapy, late-stage manufacturing, process scale-up, regulatory engagement, and organization building within cell therapy. Location: Santa Monica or Oceanside, CA, on-site; travel not specified.